Vaxart, Inc.
VXRT
$0.38
$0.00-0.16%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 784.27% | 479.58% | 433.43% | 288.94% | 303.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 784.27% | 479.58% | 433.43% | 288.94% | 303.27% |
| Cost of Revenue | 170.25% | 78.55% | 27.26% | 8.91% | -10.33% |
| Gross Profit | 37.63% | 28.31% | 34.27% | 25.10% | 29.02% |
| SG&A Expenses | -19.07% | -20.84% | -19.78% | -7.99% | -5.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 122.75% | 53.11% | 15.24% | 4.70% | -9.26% |
| Operating Income | 31.88% | 26.04% | 30.16% | 20.46% | 23.18% |
| Income Before Tax | 30.08% | 25.27% | 29.03% | 18.87% | 18.92% |
| Income Tax Expenses | 19.38% | 10.75% | 11.91% | -0.38% | 150.49% |
| Earnings from Continuing Operations | 29.91% | 25.13% | 28.90% | 18.82% | 18.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.91% | 25.13% | 28.90% | 18.82% | 18.73% |
| EBIT | 31.88% | 26.04% | 30.16% | 20.46% | 23.18% |
| EBITDA | 36.13% | 29.67% | 34.02% | 23.13% | 26.30% |
| EPS Basic | 46.83% | 47.19% | 49.90% | 40.40% | 35.04% |
| Normalized Basic EPS | 46.93% | 47.27% | 50.01% | 40.47% | 37.27% |
| EPS Diluted | 46.83% | 47.19% | 49.90% | 40.40% | 35.04% |
| Normalized Diluted EPS | 46.93% | 47.27% | 50.01% | 40.47% | 37.27% |
| Average Basic Shares Outstanding | 26.28% | 40.77% | 44.06% | 42.18% | 29.43% |
| Average Diluted Shares Outstanding | 26.28% | 40.77% | 44.06% | 42.18% | 29.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |